Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chlamydiosis
Outcome for C. trachomatis infection doesn't differ by antibiotic choice
February 17th, 2005
A study from England found no difference in outcome using doxycycline, oxytetracycline, erythromycin, or azithromycin for treating Chlamydia trachomatis infection. "A national opportunistic chlamydia screening program, mainly targeting young sexually active women, is gradually being introduced across the U.K. and in future will predominantly occur in primary care sites. The relative efficacy of recommended antibiotic treatments for chlamydia has been poorly studied and especially that of single dose azithromycin," said J.M. Tobin and colleagues. The Department of Health conducted a pilot study at St. Mary's Hospital, Portsmouth, where Tobin...
Source: Women's Health Weekly (2005-02-17)
|
